JUL 18, 2016 12:21 PM PDT

Hybrid Lymphocytes Zap Cancer

WRITTEN BY: Kara Marker
For the first time in a human tumor, scientists from the Perelman School of Medicine at the University of Pennsylvania have discovered a “hybrid lymphocyte” - part neutrophil and part antigen-presenting cell. Will learning more about this immune cell lead to a new generation of cancer immunotherapy drugs?

In their study published in Cancer Cell, Pennsylvania scientists aimed to characterize the so-called tumor-associated neutrophil (TAN) that was found at high levels in the microenvironment of tumors in samples of early-stage lung cancer. Neutrophils are normally first-responders to an infection site, killing pathogens by engulfing them and releasing perforating enzymes. Antigen-presenting cells include a variety of different lymphocytes that intercept pathogens and display pieces of them on their cell surface for cells like T lymphocytes to recognize, warning them of an invasion. 
How Cancer Immunity Works | Image: journal.frontiersin.org
During their research, the scientists wanted to know how TANs helped reduce tumor volume. In order to potentially manipulate TAN activity for future immunotherapies, they would need to understand TAN function first. The researchers investigated closely how TAN activity affected the response of cytotoxic T cells, another immune cell type that aggressively targets tumors.

“Our findings demonstrate that the early-stage lung tumor microenvironment can drive neutrophils to differentiate into a cell subset with enhanced anti-tumor capabilities,” explained coauthor of the study Sunil Singhal, MD. “Interestingly, this hybrid population disappears as tumors enlarge.”

In addition to targeting and fighting cancer cells, cytotoxic T cells kill viruses, bacteria, and even protozoa. Cytotoxic T cells cleverly cause death in foreign cells by reprogramming their cellular machinery so they will undergo apoptosis, a process of programmed cell death.

“Perhaps if we can expand the hybrid neutrophils in patients early on, we can augment anti-tumor T cell activity,” suggested senior author of the study Evgeniy B. Eruslanov, PhD. Considering the role of cytotoxic T cells in other pathologies in addition to cancer, therapy using hybrid neutrophils could be useful for multiple diseases in the future. 
 


Sources: University of Pennsylvania School of Medicine, Immunobiology: The Immune System in Health and Disease. 5th edition., PubMed Health, Nature
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 27, 2018
Immunology
JUN 27, 2018
Immune Cells Responsible for Chemo-induced Diarrhea
While studying specific immune cells in the context of chronic itching in the skin, two Washington University School of Medicine scientists discovered that...
JUL 06, 2018
Cell & Molecular Biology
JUL 06, 2018
Small Molecules Found to Dial Down Autoimmunity
Scientists have now identified two combinations of small molecules that tamp down a protein called STING....
JUL 15, 2018
Immunology
JUL 15, 2018
Enzyme Pathway Mediates Immune Response to Chagas Disease
The enzyme, PI3Kγ, regulates the immune response to T. cruzi, the cause of Chagas Disease. Manipulation of this enzyme may lead to better treatment of T. cruzi....
JUL 23, 2018
Immunology
JUL 23, 2018
Obesity Associated Inflammation Leads to Chronic Health Issues
Inflammation caused by harmful oxidized lipids increases in individuals with obesity and may contribute to chronic disease development....
AUG 06, 2018
Immunology
AUG 06, 2018
Maternal Dengue Immunity Protects Against Infant Zika Infection
Maternal Dengue immunity produces CD8+ T cells that protect against fetal Zika infection preventing zika-related malformations....
SEP 11, 2018
Cannabis Sciences
SEP 11, 2018
The Potential Anti-cancer Effects of Cannabinoids
They're known for helping to reduce the impact of cancer drug side effects, but it's possible that cannabinoids themselves are cancer fighters....
Loading Comments...